Skip to main content

Clinical Picture of Humoral Hypercalcemia of Malignancy

  • Chapter
Hypercalcemia of Malignancy

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 137))

Abstract

Hypercalcemia is generally the symptom of a disease which requires treatment. Only in rare conditions such as hypocalciuric hypercalcemia or truly asymptomatic, nonprogressive primary hyperparathyroidism is observation of hypercalcemia without treatment justified. In such cases, hypercalcemia is mild. Severely elevated plasma levels regardless of the underlying disease cause symptoms which are summarized as the “hypercalcemic syndrome” (Table 1). All such symptoms are functional and can be reversed by lowering calcium levels to normal. Single symptoms are not enough to diagnose a disease, but the more disturbances that are present in the patient, the more a plasma calcium determination is necessary to exclude hypercalcemia. Hypercalcemia is still not a common finding even in hospital patients although its frequency may vary between 0.6% (Shek et al. 1990) and 3.6% (Keating et al. 1969).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Baechler R, Sauter C, Honegger HP, Oelz O (1985) Hypercalciämie bei Non-Hodgkin-Lymphomen. Schweiz Med Wochenschr 115:332–334

    PubMed  CAS  Google Scholar 

  • Battin MB (1983) The least worst death. Hasting Center Rep 13:13–16

    Article  CAS  Google Scholar 

  • Bezwoda WR, Derman D, Zaltzman M, de Moor NG, Lange M (1980) Tamoxifen and hypercalcaemia. S Afr Med J 58:821–822

    PubMed  CAS  Google Scholar 

  • Boisaubin EV, Lynch GR, Dresser R (1991) Hypercalcemia of advanced malignancy: decision making and the quality of death. Am J Med Sci 301:314–318

    Article  PubMed  CAS  Google Scholar 

  • Burkhardt E, Kistler HJ (1981) Hypercalciämie bei hospitalisierten Patienten. Schweiz Med Wochenschr 111:2017–2023

    PubMed  CAS  Google Scholar 

  • Herrmann JM, Schonecke OW, Raue F, Ziegler R (1983) Primärer Hyperparathy-roidismus. Psychische Faktoren vor und nach Parathyroidektomie. Munch Med Wochenschr 125:369–371

    CAS  Google Scholar 

  • Keating FRJ, Jones JD, Elevback LR (1969) Distribution of serum calcium and phosphorus values in unselected ambulatory patients. J Lab Clin Med 74:507–514

    PubMed  Google Scholar 

  • Kristoffersson A, Boström A, Söderberg T (1992) Muscle strength is improved after parathyroidectomy in patients with primary hyperparathyroidism. Br J Surg 79: 165–168

    Article  PubMed  CAS  Google Scholar 

  • Lins LE (1979) Renal function in hypercalcemia. A clinical and experimental study. Acta Med Scand [Suppl] 632:1–46

    CAS  Google Scholar 

  • March R, Ulin R, Puccio C, Savino J, Arlin Z, Ahmed T, Mittelman A (1991) Hypercalcemia associated with adenocarcinoma of the rectum. A case report and review of the literature. Anticancer Res 11:2029–2030

    PubMed  CAS  Google Scholar 

  • Mok LLS, Nickols GA, Thompson JC, Cooper CW (1989) Parathyroid hormone as a smooth muscle relaxant. Endocrine Rev 10:420–436

    Article  CAS  Google Scholar 

  • Mundy GR (1987) The hypercalcemia of malignancy. Kidney Int 31:142–155

    Article  PubMed  CAS  Google Scholar 

  • Myers WPL (1960) Hypercalcemia in neoplastic disease. Arch Surg 80:308–318

    PubMed  CAS  Google Scholar 

  • Ralston SH, Gallacher SJ, Campbell J, Boyle IT (1990) Cancer-associated hypercalcemia. Morbidity and mortality. Ann Intern Med 112:499–504

    PubMed  CAS  Google Scholar 

  • Raue F, Jacubeit T, Minne H, Herfarth C, Ziegler R (1989) Primärer Hyperparathy-reoidismus — Änderung eines Krankheitsbildes. Med Klin 84:178–182

    CAS  Google Scholar 

  • Scharia SH, Minne HW, Sattar P, Mende U, Blind E, Schmidt-Gayk H, Wüster C, Ho T, Ziegler R (1987) Therapie der Tumorhypercalciämie und Clodronat. Dtsch Med Wochenschr 112:1121–1125

    Article  Google Scholar 

  • Shek CC, Natkunam A, Tsang V, Cockram CS, Swaminathan R (1990) Incidence, causes and mechanism of hypercalcaemia in a hospital population in Hong Kong. QJ Med 77:1277–1285

    CAS  Google Scholar 

  • Thiébaud D, Portmann L, Jaeger P, Jacquet AF, Burckhardt P (1986) Oral versus intravenous AHPrBP (APD) in the treatment of hypercalcemia of malignancy. Bone 7:247–253

    Article  PubMed  Google Scholar 

  • Villalon AH, Tattersall MHN, Fox RM, Woods RL (1979) Hypercalcaemia after tamoxifen for breast cancer: a sign of tumour response? Br Med J 2:1329–1330

    Article  PubMed  CAS  Google Scholar 

  • Ziegler R, Minne H, Schultheis KH, Feyen H (1974) Das diagnostische Problem eines primären Hyperparathyreoidismus bei anderen hypercalciämischen Erkrankungen. Verh Dtsch Ges Inn Med 80:1365–1368

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ziegler, R. (1994). Clinical Picture of Humoral Hypercalcemia of Malignancy. In: Raue, F. (eds) Hypercalcemia of Malignancy. Recent Results in Cancer Research, vol 137. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85073-8_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85073-8_6

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-85075-2

  • Online ISBN: 978-3-642-85073-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics